SCHEMBL11558147

SCHEMBL11558147

CCC(=O)N1CCCCCC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.59
MEN1 O00255 1/20 0.59
KMT2A Q03164 1/20 0.59
TDP1 Q9NUW8 1/20 0.59
ATM Q13315 1/20 0.54
EPHX2 P34913 2/20 0.53
GAA P10253 1/20 0.50
ALDH1A1 P00352 4/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
HTT P42858 1/20 0.47
BLM P54132 1/20 0.47
HPGD P15428 1/20 0.46
CHRNB2 P17787 2/20 0.45
CHRNA3 P32297 2/20 0.45
CHRNA4 P43681 2/20 0.45
CHRNB3 Q05901 1/20 0.45
CHRNA6 Q15825 1/20 0.45
BIRC2 Q13490 1/20 0.44
CHRNB4 P30926 1/20 0.43
CHRNA7 P36544 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14518698 1.00 L3MBTL1 (0.59) L3MBTL1MEN1KMT2ATDP1ATM
SCHEMBL18373854 1.00 L3MBTL1 (0.59) L3MBTL1MEN1KMT2ATDP1ATM
SCHEMBL18373912 1.00 L3MBTL1 (0.59) L3MBTL1MEN1KMT2ATDP1ATM
SCHEMBL765761 1.00 L3MBTL1 (0.59) L3MBTL1MEN1KMT2ATDP1ATM
SCHEMBL7247970 1.00 L3MBTL1 (0.59) L3MBTL1MEN1KMT2ATDP1ATM
Hydrochloric Acid SCHEMBL11682977 0.97 L3MBTL1 (0.57) L3MBTL1MEN1KMT2ATDP1ATM
SCHEMBL299507 0.97
SCHEMBL21765879 0.95 L3MBTL1 (0.56) L3MBTL1MEN1KMT2ATDP1ATM
Ammonia Solution, Strong SCHEMBL27829669 0.95 L3MBTL1 (0.56) L3MBTL1MEN1KMT2ATDP1ATM
Hydrochloric Acid SCHEMBL5556862 0.95 L3MBTL1 (0.56) L3MBTL1MEN1KMT2ATDP1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230402275-A1 WASHING SOLUTION AND WASHING METHOD FOR SEMICONDUCTOR SUBSTRATE FUJIFILM CORPORATION (JP) 2023-12-14 US disclosed
US-20230402275-A1 WASHING SOLUTION AND WASHING METHOD FOR SEMICONDUCTOR SUBSTRATE FUJIFILM CORPORATION (JP) 2023-12-14 US disclosed
US-20230365902-A1 COMPOSITION AND SUBSTRATE WASHING METHOD FUJIFILM CORPORATION (JP) 2023-11-16 US disclosed
US-20230365902-A1 COMPOSITION AND SUBSTRATE WASHING METHOD FUJIFILM CORPORATION (JP) 2023-11-16 US disclosed
US-20230287304-A1 TREATMENT LIQUID AND SUBSTRATE TREATMENT METHOD FUJIFILM CORPORATION (JP) 2023-09-14 US disclosed
US-20230287304-A1 TREATMENT LIQUID AND SUBSTRATE TREATMENT METHOD FUJIFILM CORPORATION (JP) 2023-09-14 US disclosed
US-20230212485-A1 TREATMENT LIQUID AND SUBSTRATE WASHING METHOD FUJIFILM CORPORATION (JP) 2023-07-06 US disclosed
US-20230212485-A1 TREATMENT LIQUID AND SUBSTRATE WASHING METHOD FUJIFILM CORPORATION (JP) 2023-07-06 US disclosed
US-20230112048-A1 CHEMICAL LIQUID AND TREATMENT METHOD FUJIFILM CORPORATION (JP) 2023-04-13 US disclosed
US-20230019032-A1 BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2023-01-19 US disclosed
US-7592349-B2 Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors IRM LLC (BM) 2009-09-22 US disclosed
US-7563894-B2 Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors IRM LLC (BM) 2009-07-21 US disclosed
US-20090012094-A1 DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS IRM LLC, A DELAWARE LIMITED LIABILITY COMAPNY (BM) 2009-01-08 US disclosed
US-20080167308-A1 DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS IRM LLC, A DELAWARE LIMITED LIABILITY COMAPNY (BM) 2008-07-10 US disclosed
US-20080146546-A1 Bicyclic and Tricyclic Heteroaromatic Compounds NEUROGEN CORPORATION 2008-06-19 US disclosed
US-20080139559-A1 DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS IRM LLC, A DELAWARE LIMITED LIABILITY COMAPNY (BM) 2008-06-12 US disclosed
US-20080139597-A1 DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS IRM LLC, A DELAWARE LIMITED LIABILITY COMAPNY (BM) 2008-06-12 US disclosed
US-20070149538-A1 Diarylamine-Containing Compounds and Compositions, and their use as Modulators of C-Kit Receptors IRM LLC (BM) 2007-06-28 US disclosed
US-4149941-A ELECTROLYTIC ALKOXYLATION HOECHST AKTIENGESELLSCHAFT (DE) 1979-04-17 US disclosed
US-4118500-A Fungicidal alkoxy mono- and dialkoxy N-substituted cyclic amines HOECHST AKTIENGESELLSCHAFT (DE) 1978-10-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080146546-A1 Bicyclic and Tricyclic Heteroaromatic Compounds GABBR1, GABBR2, GABRA4 L3MBTL1 3351/4885MEN1 3858/4885KMT2A 2326/4885
US-20230019032-A1 BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS MAPK1, ALK, MAP3K1 L3MBTL1 914/4885MEN1 1644/4885KMT2A 968/4885
US-20090012094-A1 DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS KIT, PRKCH, PRKCE L3MBTL1 4630/4885MEN1 2421/4885KMT2A 646/4885
US-20080139597-A1 DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS KIT, PRKCH, PRKCE L3MBTL1 4630/4885MEN1 2421/4885KMT2A 646/4885
US-20070149538-A1 Diarylamine-Containing Compounds and Compositions, and their use as Modulators of C-Kit Receptors KIT, PRKCH, PRKCE L3MBTL1 4630/4885MEN1 2421/4885KMT2A 646/4885
US-20080167308-A1 DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS KIT, PRKCH, PRKCE L3MBTL1 4630/4885MEN1 2421/4885KMT2A 646/4885
US-20080139559-A1 DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS KIT, PRKCH, PRKCE L3MBTL1 4630/4885MEN1 2421/4885KMT2A 646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.